Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IDEXX LABORATORIES INC /DEIDXX · Entity 3057 | Senior Vice President | February 23, 2022 | February 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IDEXX LABORATORIES INC /DE
Report date February 23, 2022 · Filed February 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,329.478 |
Ending reported balance
After 2022-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-23 · Exercise / conversion · Acquired 706 · Balance 18,436.478 Row 2 · 2022-02-23 · Exercise / conversion · Acquired 1,893 · Balance 20,329.478 |
| Incentive Stock Option (right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $141.60 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2022-02-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-23 · Exercise / conversion · Disposed 706 · Balance 0 F3: Not applicable. F1: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. |
| Non-Qualified Stock Option (right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $288.78 · Expires 2030-02-13 | Direct | 3,784 |
Reported balance
After 2022-02-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-23 · Exercise / conversion · Disposed 1,893 · Balance 3,784 F3: Not applicable. F2: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
F2: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
F3: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 785 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,596 Underlying: Common Stock · 785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F9 · price: Not applicable. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F3 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 483 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483 Underlying: Common Stock · 483 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 7,186 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,186 Underlying: Common Stock · 7,186 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: Not applicable. F1 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 428 | $206.94 | $88,570.32 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,678 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 7, 2019 22:07 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 997 | $209.08 | $208,454.45 |
DisclosureSEC source: 0001567619-19-002653 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,693 F1 · balance_after: Includes a total of 50 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 28, 2018 and December 31, 2018. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 2,180 | Not disclosed Strike: $45.84 | Not disclosed |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,180 shares Expires 2020-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F5 · derivative.exercise_date: Grant of option to buy 1,090 shares of Issuer common stock that vested in one installment on February 14, 2018, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 2,286 | Not disclosed Strike: $43.71 | Not disclosed |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · derivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,286 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy 1,143 shares of Issuer common stock that vested in one installment on February 14, 2017, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 2,180 | $45.84 | $99,931.20 |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 2,286 | $43.71 | $99,921.06 |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 11,372 | Not disclosed Strike: $43.71 | Not disclosed |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · derivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,372 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy 7,394 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2013, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 11,372 | $242.71 | $2,760,071.96 |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,174 F2 · price: Represents the weighted average sales price of the shares sold ranging from a low of $242.51 to a high of $243.25 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 22:04 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 11,372 | $43.71 | $497,070.12 |
DisclosureSEC source: 0001567619-18-001757 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 24 shares shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2018 Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:44 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,626 | $204.37 | $332,305.62 |
DisclosureSEC source: 0001140361-18-026603 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,150 F1 · balance_after: Includes 38 shares shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 30, 2018. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 14 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,811 Underlying: Common Stock · 212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. F11 · price: Not applicable. F10 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. F10 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 13 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,023 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. F11 · price: Not applicable. F9 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. F9 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 12 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,429 Underlying: Common Stock · 346 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F11 · price: Not applicable. F8 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F8 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 11 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,775 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the Stock Split. F11 · price: Not applicable. F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the Stock Split. F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 10 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,057 Underlying: Common Stock · 326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F11 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 841 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,383 Underlying: Common Stock · 841 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019. F11 · price: Not applicable. F5 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019. F5 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantIncentive Stock Option (right-to-buy) · Derivative | 560 | Not disclosed Strike: $178.26 | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560 Underlying: Common Stock · 560 shares Expires 2028-02-13 F11 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 8,007 | Not disclosed Strike: $178.26 | Not disclosed |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,007 Underlying: Common Stock · 8,007 shares Expires 2028-02-13 F11 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 475 | $178.26 | $84,673.50 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,738 F2 · price: Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-008875 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 33 shares of shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 29, 2017. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 23:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 558 | $156.01 | $87,051.35 |
DisclosureSEC source: 0001140361-17-044911 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 23:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,442 | $156.09 | $225,085.96 |
DisclosureSEC source: 0001140361-17-044911 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,960 F1 · price: Represents the weighted average sales price of the shares sold ranging from a low of $156.05 to a high of $156.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes a total of 70 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2017 and September 29, 2017. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 21:40 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 2,572 | $166.90 | $429,271.94 |
DisclosureSEC source: 0001140361-17-023352 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,332 F1 · balance_after: Includes 47 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 14 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,868 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. F9 · price: Not applicable. F8 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. F8 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 13 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,274 Underlying: Common Stock · 346 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F9 · price: Not applicable. F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 12 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,620 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split. F9 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 11 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,902 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the Stock Split. F9 · price: Not applicable. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the Stock Split. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 342 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 10 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,229 Underlying: Common Stock · 342 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2013. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F9 · price: Not applicable. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2013. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2013. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 1,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,571 Underlying: Common Stock · 1,059 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. F9 · price: Not applicable. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. F3 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantIncentive Stock Option (right-to-buy) · Derivative | 706 | Not disclosed Strike: $141.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706 Underlying: Common Stock · 706 shares Expires 2027-02-13 F9 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 10,386 | Not disclosed Strike: $141.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,386 Underlying: Common Stock · 10,386 shares Expires 2027-02-13 F9 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 575 | $141.60 | $81,420.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,857 F1 · price: Closing price of Issuer's common stock on the NASDAQ market on February 14, 2017. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 17, 2017 00:23 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 342 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008021 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.